DNM1L and Parkinson disease: Interestingly, pharmacological inhibition of Drp-1 by Mdivi-1 in PD rats treated with dopamine receptor D1 antagonist, significantly reversed behavioral deficits, adjusted mitochondrial functions, biogenesis and enhanced the number of newborn DAergic neurons in substantia nigra pars compacta.